Correlation Between Merck and Biofrontera

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck and Biofrontera at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Biofrontera into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Biofrontera, you can compare the effects of market volatilities on Merck and Biofrontera and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Biofrontera. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Biofrontera.

Diversification Opportunities for Merck and Biofrontera

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Merck and Biofrontera is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Biofrontera in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biofrontera and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Biofrontera. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biofrontera has no effect on the direction of Merck i.e., Merck and Biofrontera go up and down completely randomly.

Pair Corralation between Merck and Biofrontera

Considering the 90-day investment horizon Merck Company is expected to under-perform the Biofrontera. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 8.35 times less risky than Biofrontera. The stock trades about -0.1 of its potential returns per unit of risk. The Biofrontera is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  89.00  in Biofrontera on August 28, 2024 and sell it today you would earn a total of  3.00  from holding Biofrontera or generate 3.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Merck Company  vs.  Biofrontera

 Performance 
       Timeline  
Merck Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Biofrontera 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Biofrontera are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, Biofrontera may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Merck and Biofrontera Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck and Biofrontera

The main advantage of trading using opposite Merck and Biofrontera positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Biofrontera can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofrontera will offset losses from the drop in Biofrontera's long position.
The idea behind Merck Company and Biofrontera pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Global Correlations
Find global opportunities by holding instruments from different markets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments